SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals informs about board meeting

03 Feb 2020 Evaluate

SMS Pharmaceuticals has informed that pursuant to Regulation 29 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Sec, 173 of the Companies Act, 2013, a meeting of the Board of Directors of the Company, to consider and approve the Un-audited Financial results of the Company for the third Quarter and nine months ended 31st December, 2019. The company has informed that Insider Trading window of the Company shall remain closed till 14th February, 2020 in view of the above mentioned Board Meeting.

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

377.40 -0.75 (-0.20%)
25-Jun-2026 12:21 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1875.00
Dr. Reddys Labs. 1347.70
Cipla 1444.90
Zydus Lifesciences 1100.00
Lupin 2364.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: